Association of Sleep Duration with Cardiovascular Disease Risk in Type 2 Diabetes Patients: Analysis Using Different Models. حسب Zhi Jin (3742471)

الموضوعات:

The windows show the final results reflecting the increase or decrease in the GRF and JRF calculations. حسب Amany Eid Abd El-Tawab (13864185)

Droplet boiling modes at different temperatures. حسب Lei Bai (631944)

الموضوعات:

Correlation analysis of the change of executive functions with the decrease of mobile phone addiction index and the increase of mindfulness level. حسب Jizhao Li (5856650)

الموضوعات:

Sex-differentiated risk signal volcano plot for finasteride. حسب Xiaoling Zhong (181270)

الموضوعات:

Switching patterns of ICS/LABA. حسب Rieko Kondo (10010647)

الموضوعات:

Factors associated with exacerbations. حسب Rieko Kondo (10010647)

الموضوعات:

Definition of each exacerbation. حسب Rieko Kondo (10010647)

الموضوعات:

Definitions of treatment step classification. حسب Rieko Kondo (10010647)

الموضوعات:

Sensitivity analyses of breakthrough exacerbations. حسب Rieko Kondo (10010647)

الموضوعات:

Baseline characteristics of patients. حسب Rieko Kondo (10010647)

الموضوعات:

Data for primary and sensitivity analysis. حسب Rieko Kondo (10010647)

الموضوعات:

Study design. حسب Rieko Kondo (10010647)

الموضوعات:

Odds ratios for each case period compared with the control period. حسب Rieko Kondo (10010647)

الموضوعات:

Sensitivity analysis of the group who had an exacerbation before the index date. حسب Rieko Kondo (10010647)

الموضوعات:

Initial post-switch visits and SABA prescriptions in each period. حسب Rieko Kondo (10010647)

الموضوعات:

Flow of eligible patients. حسب Rieko Kondo (10010647)

الموضوعات:

ICS/LABA before and after switch. حسب Rieko Kondo (10010647)

الموضوعات:

Diseases excluded from the analysis. حسب Rieko Kondo (10010647)

الموضوعات:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"